Interrogating the druggable genome with structural informatics

被引:34
作者
Hambly, Kevin [1 ]
Danzer, Joseph [1 ]
Muskal, Steven [1 ]
Debe, Derek A. [1 ]
机构
[1] Eidogen Sertanty Inc, San Diego, CA 92121 USA
关键词
structure-based drug design; druggable genome; protein structures; ligand binding sites; drug targets; structural genomics;
D O I
10.1007/s11030-006-9035-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Structural genomics projects are producing protein structure data at an unprecedented rate. In this paper, we present the Target Informatics Platform (TIP), a novel structural informatics approach for amplifying the rapidly expanding body of experimental protein structure information to enhance the discovery and optimization of small molecule protein modulators on a genomic scale. In TIP, existing experimental structure information is augmented using a homology modeling approach, and binding sites across multiple target families are compared using a clique detection algorithm. We report here a detailed analysis of the structural coverage for the set of druggable human targets, highlighting drug target families where the level of structural knowledge is currently quite high, as well as those areas where structural knowledge is sparse. Furthermore, we demonstrate the utility of TIP's intra- and inter-family binding site similarity analysis using a series of retrospective case studies. Our analysis underscores the utility of a structural informatics infrastructure for extracting drug discovery-relevant information from structural data, aiding researchers in the identification of lead discovery and optimization opportunities as well as potential "off-target" liabilities.
引用
收藏
页码:273 / 281
页数:9
相关论文
共 29 条
[1]   BASIC LOCAL ALIGNMENT SEARCH TOOL [J].
ALTSCHUL, SF ;
GISH, W ;
MILLER, W ;
MYERS, EW ;
LIPMAN, DJ .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) :403-410
[2]   SCOP database in 2004: refinements integrate structure and sequence family data [J].
Andreeva, A ;
Howorth, D ;
Brenner, SE ;
Hubbard, TJP ;
Chothia, C ;
Murzin, AG .
NUCLEIC ACIDS RESEARCH, 2004, 32 :D226-D229
[3]  
Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkp985, 10.1093/nar/gkr1065, 10.1093/nar/gkh121]
[4]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[5]   Nuclear receptor peroxisome proliferator-activated receptor-γ is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen [J].
Bernardo, A ;
Ajmone-Cat, MA ;
Gasparini, L ;
Ongini, E ;
Minghetti, L .
JOURNAL OF NEUROCHEMISTRY, 2005, 92 (04) :895-903
[6]   Gene3D: structural assignments for the biologist and bioinformaticist alike [J].
Buchan, DWA ;
Rison, SCG ;
Bray, JE ;
Lee, D ;
Pearl, F ;
Thornton, JM ;
Orengo, CA .
NUCLEIC ACIDS RESEARCH, 2003, 31 (01) :469-473
[7]   Molecular modelling of drug targets: The past, the present and the future [J].
Dahl, SG ;
Sylte, I .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2005, 96 (03) :151-155
[8]  
DEBE DA, STRUCTFAST EXTREME R
[9]   Comparison of a vasopeptidase inhibitor with neutral endopeptidase and angiotensin-converting enzyme inhibitors on bradykinin metabolism in the rat coronary bed [J].
Dumoulin, MJ ;
Adam, A ;
Rouleau, JL ;
Lamontagne, D .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 37 (04) :359-366
[10]   Conception and pharmacodynamic profile of drospirenone [J].
Elger, W ;
Beier, S ;
Pollow, K ;
Garfield, R ;
Shi, SQ ;
Hillisch, A .
STEROIDS, 2003, 68 (10-13) :891-905